ZEISS Medical Technology, one of the world’s leading medical technology companies, has announced a strategic collaboration with Envision Health Technologies, a digital eye health company, to advance glaucoma care using gamified virtual reality (VR) technology. 

 

The partnership is designed to strengthen scientific and clinical credibility in VR-based visual function testing, building on ZEISS’ long-standing expertise in perimetry.

 

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows, fueling interest in portable, software-driven approaches to visual function testing. Through the collaboration, both companies aim to combine clinical expertise with digital innovation to develop more patient-centered tools for modern glaucoma care.

 

“As glaucoma care continues to evolve, clinicians are looking for solutions that improve patient accessibility, flexibility and experience without compromising clinical confidence. 

 

"Our collaboration with Envision Health Technologies reflects ZEISS’ commitment to advancing practical, clinician-driven innovation that can help expand access to visual function testing across a range of care settings,” says Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology.

 

“We believe the future of visual function testing should be more accessible, flexible, and patient-centered while remaining grounded in clinical rigor. 

 

"Collaborating with ZEISS allows us to combine cutting-edge software innovation with decades of trusted market leadership in perimetry to help advance more practical solutions for real-world glaucoma care,” says Lama A. Al-Aswad, Founder and CEO of Envision Health Technologies. 

 

The collaboration positions both companies at the intersection of clinical ophthalmology and immersive technology, with a shared goal of shaping the next generation of glaucoma diagnostics through VR-based innovation grounded in clinical practice.